Estimated treatment costs for multidrug-resistant TB in the United States

Int J Tuberc Lung Dis. 2024 Apr 1;28(4):214-215. doi: 10.5588/ijtld.23.0621.
No abstract available

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Health Care Costs
  • Humans
  • Tuberculosis, Multidrug-Resistant* / drug therapy
  • Tuberculosis, Multidrug-Resistant* / epidemiology
  • United States / epidemiology

Substances

  • Antitubercular Agents